BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26117067)

  • 1. BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls.
    Lisiecka DM; O'Hanlon E; Fagan AJ; Carballedo A; Morris D; Suckling J; Frodl T
    J Affect Disord; 2015 Sep; 184():239-44. PubMed ID: 26117067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor Val66Met polymorphism affects cortical thickness of rostral anterior cingulate in patients with major depressive disorder.
    Shen Z; Lu Y; Jiang H; Ye J; Zhou C; He M; Li N; Xu X; Cheng Y
    Neuroreport; 2020 Nov; 31(16):1146-1153. PubMed ID: 32991522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of 5-HTTLPR and Val66Met polymorphisms on cortical thickness and volume in limbic and paralimbic regions in depression: a preliminary study.
    Jaworska N; MacMaster FP; Foster J; Ramasubbu R
    BMC Psychiatry; 2016 Mar; 16():61. PubMed ID: 26976307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.
    Carballedo A; Amico F; Ugwu I; Fagan AJ; Fahey C; Morris D; Meaney JF; Leemans A; Frodl T
    Am J Med Genet B Neuropsychiatr Genet; 2012 Jul; 159B(5):537-48. PubMed ID: 22585743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.
    Cardoner N; Soria V; Gratacòs M; Hernández-Ribas R; Pujol J; López-Solà M; Deus J; Urretavizcaya M; Estivill X; Menchón JM; Soriano-Mas C
    Depress Anxiety; 2013 Mar; 30(3):225-33. PubMed ID: 23165919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of brain-derived neurotrophic factor genetic Val66Met polymorphism with severity of depression, efficacy of fluoxetine and its side effects in Chinese major depressive patients.
    Zou YF; Wang Y; Liu P; Feng XL; Wang BY; Zang TH; Yu X; Wei J; Liu ZC; Liu Y; Tao M; Li HC; Li KQ; Hu J; Li M; Zhang KR; Ye DQ; Xu XP
    Neuropsychobiology; 2010; 61(2):71-8. PubMed ID: 20016225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder.
    Legge RM; Sendi S; Cole JH; Cohen-Woods S; Costafreda SG; Simmons A; Farmer AE; Aitchison KJ; McGuffin P; Fu CH
    Br J Psychiatry; 2015 May; 206(5):379-84. PubMed ID: 25745134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.
    Colle R; Trabado S; David DJ; Brailly-Tabard S; Hardy P; Falissard B; Fève B; Becquemont L; Verstuyft C; Corruble E
    Neuropsychobiology; 2017; 75(1):39-45. PubMed ID: 28848102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele.
    Cao B; Bauer IE; Sharma AN; Mwangi B; Frazier T; Lavagnino L; Zunta-Soares GB; Walss-Bass C; Glahn DC; Kapczinski F; Nielsen DA; Soares JC
    J Affect Disord; 2016 Jul; 198():198-205. PubMed ID: 27018938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between a BDNF gene polymorphism and the brain volume in treatment-naive patients with major depressive disorder: A VBM analysis of brain MRI.
    Ide S; Kakeda S; Watanabe K; Yoshimura R; Abe O; Hayashi K; Ueda I; Kishi T; Katsuki A; Umene-Nakano W; Iwata N; Nakamura J; Korogi Y
    Psychiatry Res; 2015 Aug; 233(2):120-4. PubMed ID: 26078197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of 5-HTTLPR and BDNF Val66Met polymorphisms on neurostructural changes in major depressive disorder.
    Han KM; Choi S; Kim A; Kang J; Won E; Tae WS; Kim YK; Lee MS; Ham BJ
    Psychiatry Res Neuroimaging; 2018 Mar; 273():25-34. PubMed ID: 29414128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms and plasma BDNF levels among Malaysian major depressive disorder patients.
    Aldoghachi AF; Tor YS; Redzun SZ; Lokman KAB; Razaq NAA; Shahbudin AF; Badamasi IM; Cheah PS; Stanslas J; Veerakumarasivam A; Rosli R; Ibrahim N; Lye MS; Ling KH
    PLoS One; 2019; 14(1):e0211241. PubMed ID: 30677092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.
    Pathak P; Mehra A; Ram S; Pal A; Grover S
    Behav Brain Res; 2022 Jul; 430():113931. PubMed ID: 35605794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.
    Verhagen M; van der Meij A; van Deurzen PA; Janzing JG; Arias-Vásquez A; Buitelaar JK; Franke B
    Mol Psychiatry; 2010 Mar; 15(3):260-71. PubMed ID: 18852698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
    Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
    Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF-Dependent Effects on Amygdala-Cortical Circuitry and Depression Risk in Children and Youth.
    Wheeler AL; Felsky D; Viviano JD; Stojanovski S; Ameis SH; Szatmari P; Lerch JP; Chakravarty MM; Voineskos AN
    Cereb Cortex; 2018 May; 28(5):1760-1770. PubMed ID: 28387866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.
    Suchanek R; Owczarek A; Kowalczyk M; Kucia K; Kowalski J
    J Mol Neurosci; 2011 Mar; 43(3):524-30. PubMed ID: 21103954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.